Found 0 matching trials
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) PHASE2 This is a clinical trial that will compare survival and sickle related outc...
Show More Location
Benioff Children's Hospital at Oakland
Learn More & Join Trial
Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years PHASE3 The purpose of the study is to evaluate the immunogenicity and safety of Ki...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older PHASE3 The purpose of this study is to evaluate the immunogenicity and safety of G...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS) PHASE2 The goal of this clinical research study is to learn if 5-aza-2 deoxycytidi...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Efficacy, Safety and Pharmacokinetics of Sugammadex (Org 25969; MK-8616) at 3 Different Time Points After 0.6 mg/kg Esmeron® in Male Participants (P05940; MK-8616-020). PHASE2 This study investigates the efficacy, safety, and pharmacokinetics of sugam...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03) PHASE3 This study will evaluate the immunogenicity, safety, and tolerability of VA...
Show More Location
Alabama Clinical Therapeutics ( Site 0018)
Learn More & Join Trial
Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children PHASE3 This is a study to evaluate the immune response and safety of GSK Biologica...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) PHASE3 The purpose of this study is to evaluate the safety, tolerability, and immu...
Show More Location
Alabama Clinical Therapeutics ( Site 0159)
Learn More & Join Trial
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico PHASE3 Primary Objective:
1. To describe the vaccine seroprotection (antibody tit...
Show More Location
Investigational Site Number :4840001
Treatments Being Tested
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine Measles, Mumps, and Rubella Virus Vaccine Live Pneumococcal 13-valent Conjugate Vaccine Diphtheria, Tetanus, Pertussis (Acellular, Component) Poliomyelitis (inactivated) Vaccine, and Haemophilus influenza type b Conjugate Vaccine Hepatitis B Vaccine Rotavirus Vaccine, Live, Pentavalent Diphtheria, tetanus, pertussis (acellular component), hepatitis B, poliomyelitis (inactivated), and Haemophilus influenzae type b conjugate vaccine Learn More & Join Trial
Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL) PHASE2 This is a multicenter, non-randomized, open-label, phase II study evaluatin...
Show More Location
West Virginia University Cancer Institute
Learn More & Join Trial